One click against cancer! Quality of Life 19. 10. 2020 Register with one click and take your health in your hands! Patients can register for free at CureCancer - mycancer.gr and a) create their own medical file, record their medical history and therapies, and upload their test results. b) Record and keep track of their symptoms as they experience them and, in practicality, communicate with their doctor with one click whenever needed and from a distance without having to travel. The use of telemedicine in oncology is a very important change for the better and has today become a routine clinical practice in many international oncology centers. The use of CureCancer - mycancer.gr, as noted by Mrs. Galiti in the article by H Kathimerini "contributes to the increased success of therapy due to the immediate updates and communication to the doctor." We thank Archimedes- Center for Research, Innovation and Entrepreneurship of NKUA for their continuing support and the magazine “K” for hosting us. Read the complete article here (in Greek). Tags: CureCancer - mycancer.gr , prevention , telemedicine
Medication-Related Osteonecrosis of the Jaw in Cancer Therapy Events, Seminars, & Publications 13. 02. 2026 On April 2, mycancer invites you to another online seminar focusing on one of the most critical issues in modern Oncology:WEBINAR“Medication-Related Osteonecrosis of the Jaw in Cancer Therapy”Teaching...[Read more]
Medication-Related Osteonecrosis of the Jaw (MRONJ): From Theory to Practice – Advanced Training Webinar Events, Seminars, & Publications 28. 01. 2026 The Next Step in Managing Patients on Antiresorptive MedicationsOn January 16, 180 dentists attended our first webinar on MRONJ and risk assessment.The response was immediate:“The STEPS and their eval...[Read more]
Osteonecrosis of the Jaws in Cancer Medications Events, Seminars, & Publications 04. 11. 2025 Following the success of the mycancer Online Seminar Series, we are pleased to invite you to the 4th WEBINAR “Osteonecrosis of the Jaws in Cancer Medications” of the 2025 series.Our goal is to promote...[Read more]
